Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Insulet Corporation PODD

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.


Top institutional share ownership of Insulet Corporation

Name Shares Shares % change Value Value % change
Fmr Llc 10,363,288 0.0% $2,377,339 5.2%
Capital Research Global Investors 6,455,485 -4.3% $1,480,901 0.8%
Vanguard Group Inc 6,392,621 1.0% $1,466,468 6.3%
Wellington Management Group Llp 5,052,535 -2.0% $1,159,053 3.2%
BlackRock Inc. 4,807,896 1.5% $1,102,933 6.8%
Capital World Investors 4,146,258 -1.0% $951,170 4.2%
Price T Rowe Associates Inc /md/ 3,264,805 -5.9% $748,947 -0.9%
AMCPX - AMCAP FUND Class A 2,427,884 -7.7% $620,252 10.4%
SMCWX - SMALLCAP WORLD FUND INC Class A 2,399,642 -8.1% $550,478 -3.2%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 2,067,820 1.2% $474,358 6.5%

Top institutional buyers of Insulet Corporation

Name Shares % change Value % change Shares Value
VGHCX - Vanguard Health Care Fund Investor Shares 20.9% 25.3% 2,003,249 $496,405
D1 Capital Partners L.P. 7.5% 13.1% 1,328,196 $304,688
FDGRX - Fidelity Growth Company Fund 2.5% 22.6% 1,695,541 $433,160
Jpmorgan Chase & Co 2.0% 7.3% 1,462,871 $335,583
Geode Capital Management, Llc 1.6% 6.9% 926,087 $212,277
BlackRock Inc. 1.5% 6.8% 4,807,896 $1,102,933
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 1.2% 6.5% 2,067,820 $474,358
Vanguard Group Inc 1.0% 6.3% 6,392,621 $1,466,468
State Street Corp 0.8% 6.1% 1,436,952 $329,637
VIMSX - Vanguard Mid-Cap Index Fund Investor Shares 0.2% 5.5% 1,599,082 $366,829

Top institutional sellers of Insulet Corporation

Name Shares % change Value % change Shares Value
Ameriprise Financial Inc -13.5% -8.8% 1,015,699 $233,206
SMCWX - SMALLCAP WORLD FUND INC Class A -8.1% -3.2% 2,399,642 $550,478
AMCPX - AMCAP FUND Class A -7.7% 10.4% 2,427,884 $620,252
FSMEX - Medical Technology and Devices Portfolio -6.3% 12.2% 1,200,000 $306,564
Price T Rowe Associates Inc /md/ -5.9% -0.9% 3,264,805 $748,947
Capital Research Global Investors -4.3% 0.8% 6,455,485 $1,480,901
AGTHX - GROWTH FUND OF AMERICA Class A -2.7% 16.4% 1,983,163 $506,639
FSPHX - Health Care Portfolio -2.0% 17.3% 980,000 $250,361
Wellington Management Group Llp -2.0% 3.2% 5,052,535 $1,159,053
Capital World Investors -1.0% 4.2% 4,146,258 $951,170

Information provided by Fintel.io